Derek Prince, Ph.D., to Host Free Webinar on Reducing EtO Reliance and De-risking Your Supply Chain

In February 2026, Derek Prince, Ph.D., led a VH₂O₂ sterilization TechTalk at MD&M West to a full house. The response was overwhelming, and the questions didn’t stop when the session ended. Due to high demand, this session is now being offered as a live webinar, open to the broader medical device and pharmaceutical community.

Growing regulatory pressure, environmental concerns, and capacity constraints associated with ethylene oxide (EtO) sterilization have intensified the need for alternative sterilization modalities that can reduce risk and strengthen medical device supply chains. Vaporized hydrogen peroxide (VH₂O₂) sterilization has emerged as a viable next-generation solution, offering effective microbial inactivation, improved sustainability, and increased operational resilience.

In 2024, the U.S. Food and Drug Administration reclassified VH₂O₂ as an Established Category A sterilization process, with ISO 22441:2022 providing the framework for process development, validation, and routine control. VH₂O₂ sterilization demonstrates broad material compatibility and robust efficacy against a broad spectrum of microorganisms, while producing no toxic residuals and decomposing into environmentally benign byproducts.

Who should attend: Professionals in the medical device and pharmaceutical industries who want to stay informed on the evolving landscape of medical device sterilization. This includes process engineers, packaging subject matter experts (SMEs), quality assurance and regulatory affairs professionals, supply chain leaders, and anyone with an interest in medical device sterilization practices.

In this webinar, you will learn:

• The current regulatory landscape surrounding VH2O2 Medical Device Sterilization.
• Supply chain risks and risk management principles to reduce reliance on EtO.
• Applications of VH2O2 sterilization.
• Environmental considerations.